Renal replacement therapy in acute kidney injury - Authors' reply

Affiliations

¹ Département de Réanimation Médico-Chirurgicale, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France; Health Care Simulation Center, UFR SMBH, Université Sorbonne Paris Nord, Bobigny, France; Common and Rare Kidney Diseases, Sorbonne Université, INSERM, UMR-S 1155, Paris, France; Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Bobigny, France.
² Common and Rare Kidney Diseases, Sorbonne Université, INSERM, UMR-S 1155, Paris, France; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.
³ Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.
⁴ Department of Intensive Care, François Mitterrand University Hospital, Dijon, France; Department of Lipness Team, INSERM Research Center LNC-UMR1231 and LabExLipSTIC, University of Burgundy, Dijon, France; Department of Clinical Epidemiology, INSERM CIC 1432, University of Burgundy, Dijon, France.
⁵ Médecine Intensive-Réanimation, Assistance Publique-Hôpitaux de Paris, Hôpital Louis Mourier, Colombes 92110, France. Electronic address: didier.dreyfuss@aphp.fr.

Comment

Stéphane Gaudry et al. Lancet. 2021.

. 2021 Dec 19;396(10267):1975-1976.

doi: 10.1016/S0140-6736(20)32673-8.

¹ Département de Réanimation Médico-Chirurgicale, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France; Health Care Simulation Center, UFR SMBH, Université Sorbonne Paris Nord, Bobigny, France; Common and Rare Kidney Diseases, Sorbonne Université, INSERM, UMR-S 1155, Paris, France; Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Bobigny, France.
² Common and Rare Kidney Diseases, Sorbonne Université, INSERM, UMR-S 1155, Paris, France; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.
³ Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris, Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.
⁴ Department of Intensive Care, François Mitterrand University Hospital, Dijon, France; Department of Lipness Team, INSERM Research Center LNC-UMR1231 and LabExLipSTIC, University of Burgundy, Dijon, France; Department of Clinical Epidemiology, INSERM CIC 1432, University of Burgundy, Dijon, France.
⁵ Médecine Intensive-Réanimation, Assistance Publique-Hôpitaux de Paris, Hôpital Louis Mourier, Colombes 92110, France. Electronic address: didier.dreyfuss@aphp.fr.

No abstract available

Comment on

Renal replacement therapy in acute kidney injury.
Sepe V, Rampino T, Libetta C. Sepe V, et al. Lancet. 2021 Dec 19;396(10267):1974. doi: 10.1016/S0140-6736(20)32399-0. Lancet. 2021. PMID: 33341135 No abstract available.
Renal replacement therapy in acute kidney injury.
Lu Z, Yan P, Yang K, Yao L. Lu Z, et al. Lancet. 2021 Dec 19;396(10267):1974-1975. doi: 10.1016/S0140-6736(20)32405-3. Lancet. 2021. PMID: 33341136 No abstract available.